Francesco Lotti

Principal investigator.

Biotech

Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.

2023First federal award

$2.0MFederal grants as PI3 awards

0Patents grantedNone matched

0PapersOpenAlex

Career record

Federal awards and patents by year

20232026

AwardsPatents

Federal awards as principal investigator

3 awards · $2.0M

Date	Agency	Award	Amount	Company
May 11, 2026	NIH	STTR Phase II Developing RNA therapeutics for rare neurodevelopmental disorders	$845K	Dayi Therapeutics, Inc.
Dec 26, 2024	NIH	STTR Phase II Developing RNA therapeutics for rare neurodevelopmental disorders	$854K	Dayi Therapeutics, Inc.
May 1, 2023	NIH	STTR Phase I Developing RNA therapeutics for rare neurodevelopmental disorders	$300K	Dayi Therapeutics, Inc. with COLUMBIA UNIVERSITY

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#1,028

Awards as PI#822

Patents#273

From filings, awards and patents

Companies

Dayi Therapeutics, Inc.Linked by awards · Biotech

Research partners on awards

Research institutions

COLUMBIA UNIVERSITY

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.